About Karsten

Karsten leads our medtech work and our Transformation & Restructuring Practice. He brings extensive experience in end-to-end performance transformations for both pharmaceutical and medical-products companies.

Examples of his recent client work include the following:

  • assisting a global medical-products company with a two-year transformation that improved operating margins by ten percentage points
  • developing strategy for a leading orphan-disease pharmaceuticals company
  • helping a medical-products company with a 12-month program to outsource its logistics system
  • assisting a medical-products company with a cost-improvement program that improved margins by five percentage points
  • working with a private-equity–owned medical-products company on its 18-month turnaround and $4 billion sale, a project that included business-unit strategy, a new manufacturing footprint, product-cost teardown, R&D strategy, and roll out of a commercial-excellence program

Published Work

Biosimilars seven years on: Where are we and what’s next?,” McKinsey & Company, February 2013

Education

Copenhagen Business School
BS, MS, finance and accounting